rethinkPeptides Search
Menu
Study breakdown

Kappa-Opioid Stimulation Differently Affects Hypertensive vs Normal Hearts

evidence
The takeaway

Cardiac kappa-opioid receptor stimulation affected systolic function differently in hypertensive versus normotensive rat hearts, revealing disease-state-dependent opioid cardiac pharmacology.

Key finding

Cardiac kappa-opioid receptor stimulation affected systolic function differently in hypertensive versus normotensive rat hearts, revealing disease-sta

What the researchers found

Cardiac kappa-opioid receptor stimulation affected systolic function differently in hypertensive versus normotensive rat hearts, revealing disease-state-dependent opioid cardiac pharmacology.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2009.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Kappa-Opioid Stimulation Differently Affects Hypertensive vs Normal Hearts
What was found?
Cardiac kappa-opioid receptor stimulation affected systolic function differently in hypertensive versus normotensive rat hearts, revealing disease-state-dependent opioid cardiac pharmacology.

Read the original research

Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation.

American journal of physiology. Heart and circulatory physiology, 296(4), H967-75

Citation

Bolte, Craig; Newman, Gilbert; Schultz, Jo El J. (2009). Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation.. American journal of physiology. Heart and circulatory physiology, 296(4), H967-75. https://doi.org/10.1152/ajpheart.00909.2008